Gilead Sciences (NASDAQ:GILD)

merck

Merck Is Top DJIA Stock in 2015

Among the 30 stocks that comprise the Dow Jones Industrial Average (DJIA), Merck & Co. Inc. (NYSE: MRK) was among the top performers in 2014, up about 14%, nearly double ...
Read Full Story »
Biotechnology word cloud

Short Interest in Biotechs Signals Optimism

The short interest data are out for the December 31 settlement date. Biotech companies are considered a riskier group of stocks, with big upside and big downside. FDA rulings can ...
Read Full Story »
Money background. Close-up.

Gilead Continues to Recover from Express Scripts Loss

After the markets closed on Thursday, Gilead Sciences Inc. (NASDAQ: GILD) was picked up by Anthem Inc. (NYSE: ANTM) to provide its hepatitis C drug as the primary option for ...
Read Full Story »
Biotechnology word cloud

Wells Fargo’s Top Biotech Stocks for 2015

Looking back at 2014, biotechs had a phenomenal year, and this looks to continue into 2015. The NYSE Arca Biotech index was up over 45% for 2014, and Wells Fargo ...
Read Full Story »
Pills

Analyst’s 8 Top Health Care Stocks for 2015

Health care had an outstanding year in 2014. In fact the sector through last Friday was up 23.30%, which placed it third in the S&P 500 sector race, just behind ...
Read Full Story »
investor research

Top Analyst Upgrades and Downgrades: GE, Gilead, Oracle, Under Armour, El Pollo Loco and More

Stocks were trying to stage a small comeback on Tuesday after an overseas and oil induced sell-off from Monday that took the Dow Jones Industrial Average down about 300 points. ...
Read Full Story »
thumbs up

Is Gilead Already Coming Back Into Favor?

Over the past year, Gilead Sciences Inc. (NASDAQ: GILD) has been a top dog with regards to hepatitis C treatments, pulling in over $6.2 billion in sales for these treatments ...
Read Full Story »
Bull and Bear

Top Analyst Upgrades and Downgrades: Ambarella, Gilead, MarkWest, PNC, Skyworks, RigNet, Sonus and More

Stocks were indicated lower on Monday after a week of rallying took the Dow Jones Industrial Average above 18,000 and took the S&P 500 up to nearly 2,100. Investors have ...
Read Full Story »
downgrade sign

Analysts Predict Big Value Trap for Gilead Investors

AbbVie Inc. (NYSE: ABBV) and Express Scripts Holding Co. (NASDAQ: ESRX) entered into an exclusive distribution agreement following the U.S. Food and Drug Administration’s (FDA) approval of AbbVie’s hepatitis C ...
Read Full Story »
Pills

What the AbbVie and Express Script Deal Means for Gilead

AbbVie Inc. (NYSE: ABBV) received U.S. Food and Drug Administration (FDA) approval for its hepatitis C drug last Friday, and the drug will directly compete with treatments from Gilead Sciences Inc. ...
Read Full Story »
biotech

Are Investors Signaling Optimism in Biotechs Through Short Interest?

The short interest data are out for the November 28 settlement date. Biotech companies are considered a riskier group of stocks, with big upside and big downside. FDA rulings can ...
Read Full Story »
investor research

Top Analyst Upgrades and Downgrades: Cisco, DreamWorks, Lululemon, Nabors, Schlumberger, Verizon and More

Stocks were indicated much lower on Tuesday as the market is dealing with lower commodities (oil and more) and a weak China and Europe. What has been proven repeatedly in ...
Read Full Story »
DNA

Mixed Readings For Biotech Short Interest

The short interest data are out for the November 14 settlement date. Biotech companies are considered a riskier group of stocks, with big upside and big downside. FDA rulings can ...
Read Full Story »
health care

5 Health Care Stocks That Need to Play Serious Catch Up

2014 has been another amazing year for stocks, and now the bull market is closer to being six years old and stocks have risen some 200% from the inflection bottom ...
Read Full Story »
Wall Street/NYSE

Insider Selling Surges as Markets Hit Record High

With the S&P 500 and the Dow Jones Industrial Average at record highs, and the Nasdaq hitting highs not seen since 2000, the volume of insider selling reached some of ...
Read Full Story »